Clinical Trial Update: A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing delgocitinib topical cream (20 mg/g) twice daily to alitretinoin capsules once daily in adults with severe chronic hand eczema has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Eczema

Drugs mentioned

• Alitretinoin capsules (alitretinoin)
• Delgocitinib cream 20 mg/g (delgocitinib)

Snippet

Sponsor: LEO Pharma | Conditions: Chronic Hand Eczema | Phase 3 | Status: COMPLETED | Results posted: 2025-03-14